Original Article

Fibrinolysis

Authors: PHIL J. HARBRECHT M.D.

Abstract

Because of the importance of this subject in both surgical and nonsurgical clinical conditions, a review of what is known about it as of this date should be of interest. It would seem probable that at some future date, possibly not too distant, thrombolytic treatment may move from the experimental to the clinical stage.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References